Infectious mononucleosis in middle age

JAMA

Volumn 281, Issue 5, 1999, Pages 454-459

  Auwaerter, Paul G ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD SMEAR; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; EPSTEIN BARR VIRUS; HUMAN; INFECTIOUS MONONUCLEOSIS; MALE; PRIORITY JOURNAL;

EID: 0033518542     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.281.5.454     Document Type: Article

References (36)

1. Sprunt TP, Evans FA. Mononuclear leucocytosis in reaction to acute infections ("infectious mononucleosis"). Johns Hopkins Hosp Bull. 1920;31:410-417.
2. Downey H, McKinlay CA. Acute lymphadenosis compared with acute lymphatic leukemia. Arch Intern Med. 1923;32:82-112.
3. Paul JR, Bunnell WW. The presence of heterophile antibodies in infectious mononudeosis. Am J Med Sci. 1932;183:90-104.
4. Davidsohn I. Serologic diagnosis of infectious mononucleosis. JAMA. 1937;108:289-295.
5. Epstein MA, Achong BG, Barr YM. Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet. 1964;1:702-703.
6. Henle G, Henle W, Diehl V. Relation of Burkitt's tumor-associated herpes-type virus to infectious mononucleosis. Proc Natl Acad Sci U S A. 1968;59: 94-101.
7. Schooley RT. Epstein-Barr virus (infectious mononucleosis). In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases. 4th ed. New York, NY: Churchill Livingstone Inc: 1995:1364-1377.
8. Fleisher GR, Pasquariello PS, Warren WS, et al. Intrafamilial transmission of Epstein-Barr virus infections. J Pediatr. 1981;98:16-19.
9. Nye FJ. Social class and infectious mononucleosis. J Hyg (Lond). 1973;71:145-149.
10. Straus SE, Fleisher GR. Infectious mononucleosis epidemiology and pathogenesis. In: Schlossberg D, ed. Infectious Mononucleosis. 2nd ed. New York, NY: Springer-Verlag; 1989:8-28.
11. Evans AS. Infectious mononucleosis: recent developments. GP. 1969;40:127-134.
12. Henke CE, Kurland LT, Elveback LR. Infectious mononucleosis in Rochester, Minnesota, 1950 through 1969. Am J Epidemiol. 1973;98:483-490.
13. Heath CW Jr, Brodsky AL, Potolsky AI. Infectious mononucleosis in a general population. Am J Epidemiol. 1972;95:46-52.
14. Henle G, Henle W. Observations on childhood infection with the Epstein-Barr virus. J Infect Dis. 1970; 121:303-310.
15. Thorley-Lawson DA, Mann KP. Early events in Epstein-Barr virus infection provide a model for B cell activation. J Exp Med. 1985;162:45-59.
16. Straus SE, Cohen JI, Tosato G, Meier J. NIH conference: Epstein-Barr virus infections: biology, pathogenesis, and management. Ann Intern Med. 1993; 118:45-58.
17. Rickinson AB, Moss DJ. Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection. Annu Rev Immunol. 1997;15:405-431.
18. Sheldon PJ, Hemsted EH, Papamichail M, Holborow EJ. Thymic origin of atypical lymphoid cells in infectious mononucleosis. Lancet. 1973;1:1153-1155.
19. Pattengale PK, Smith RW, Perlin E. Atypical lymphocytes in acute infectious mononucleosis: identification by multiple T and B lymphocyte markers. N Engl J Med. 1974;291:1145-1148.
20. Callan MFC, Steven N, Krausa P, et al. Large clonal expansions of CD8+ T cells in acute infectious mononucleosis. Nat Med. 1996;2:906-911.
21. General features of infectious mononucleosis (roundtable discussion). In: Glade PR, ed. Infectious Mononucleosis: Proceedings of Symposium, New York, New York, April 7, 1972. Philadelphia, Pa: JB Lippincott; 1973:1-18.
22. Pullen H, Wright N, Murdoch JM. Hypersensitivity reactions to antibacterial drugs in infectious mononucleosis. Lancet. 1967;2:1176-1178.
23. Cameron D, MacBean LM. A Clinical Study of Infectious Mononucleosis and Toxoplasmosis. Baltimore, Md: Williams & Wilkins; 1973:18-23.
24. Horwitz CA, Henle W, Henle G, Schapiro R, Borken S, Bundtzen R. Infectious mononucleosis in patients aged 40 to 72 years: report of 27 cases, including 3 without heterophil-antibody responses. Medicine (Baltimore). 1983;62:256-262.
25. Axelrod P, Finestone AJ. Infectious mononucleosis in older adults. Am fam Physician. 1990;42:1599-1606.
26. Markin RS, Linder J, Zuerlein K, et al. Hepatitis in fatal infectious mononucleosis. Gastroenterology. 1987; 93:1210-1217.
27. Halevy J, Ash S. Infectious mononucleosis in hospitalized patients over forty years of age. Am J Med Sci. 1988;295:122-124.
28. Zahavi J, Seligsohn U. Unusual course of infectious mononucleosis. JAMA. 1967;200:1181-1183.
29. Finkel M, Parker GW, Fanselau HA. The hepatitis of infectious mononucleosis: experience with 235 cases. Mil Med. 1964;129:533-538.
30. Markin RS. Manifestations of Epstein-Barr virus-associated disorders in liver. Liver. 1994;14:1-13.
31. Linderholm M, Boman J, Juto P, Linde A. Comparative evaluation of nine kits for rapid diagnosis of infectious mononucleosis and Epstein-Barr virus-specific serology. J Clin Microbiol. 1994;32:259-261.
32. Linde A. Diagnosis of Epstein-Barr virus-related diseases. Scand J Infect Dis Suppl. 1996;100:83-88.
33. Henle W, Henle G, Niederman JC, Klemola E, Haltia K. Antibodies to early antigens induced by Epstein-Barr virus in infectious mononucleosis. J Infect Dis. 1971;124:58-67.
34. Straus SE. The chronic mononucleosis syndrome. J Infect Dis. 1988;157:405-412.
35. Andersson J, Ernberg I. Management of Epstein-Barr virus infections. Am J Med. 1988;85:107-115.
36. Tynell E, Aurelius E, Brandell A, et al. Acyclovir and prednisolone treatment of acute infectious mononucleosis: a multicenter, double-blind, placebo-controlled study. J Infect Dis. 1996;174:324-331.